Skip to content
Company Analysis

Nephros, Inc. NEPH

A comprehensive view of key metrics, scores, and financial health for Nephros, Inc.

Overview of Nephros, Inc.

NEPH NCM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap
Nephros, Inc. (NEPH), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $3.24, about 18.5% overvalued vs fair value, -37.7% 1Y return, placing in the top 25% of its sector.
Metrics P/E 44.8× Rev Growth 32.7% ROE 12.7% Gross Margin 61.9%
USD 3.24
2.21%
(Delayed)
• Vol 90d: 75.4%
52-Week Range
Market Cap
$35.19M
Enterprise Value
$30.49M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Weak
Valuation
Weak
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 90%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.nephros.com
HQ South Orange, NJ
Employees 31
Fiscal year Dec 31

Next Events

Earnings Nov 5 Call: Nov 5

Fair Value Snapshot

Bear Base Bull
$2
$3
$3
Current: $3.24 -19% vs base

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$18.8M
32.7%%
Gross Profit
$11.6M
33.3%%
Operating Income (GAAP)
$1.1M
19000%%
EBITDA
$1.3M
493.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
61.9%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
3
Active Leaks
2/3
Improving
1
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Nephros, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
61
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.86). High ROIC indicates the business is reinvesting at attractive rates.
  • Expanding Operating Margin Operating margin trend is positive (score 0.81). Margin expansion confirms commercial leverage is building.

Key risks

  • Gross Margin Volatility Gross margin stability is poor (score 0.30). Margin volatility undermines the consumable moat thesis.
  • Declining Capital Returns ROIC durability is weak (score 0.21). Volatility or decline in returns is a leading moat erosion signal.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
55
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing NEPH's balance between Growth (36.5%), Profitability (34.9%), and Safety (28.5%). Growth 37% Safety 29% Profitability 35%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

77th percentile vs peers
78
Key Signals
Rev Growth YoY 32.7% 87p EPS Growth YoY 14.61 99p Revenue CAGR 3Y 23.5% 77p Asset Growth YoY 21.7% 81p TSR -79.9% 4p
Strengths
  • Rev Growth YoY in top 20% of peers (32.7%, 87th percentile)
  • EPS Growth YoY in top 20% of peers (14.61, 99th percentile)
  • ROIC in top 20% of peers (11.1%, 88th percentile)
  • Net Debt/EBITDA in top 20% of peers (-4.01, 84th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (329.00, 99th percentile)
Risks

No significant risks identified for this axis.

Profitability

74th percentile vs peers
74
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

60th percentile vs peers
61
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Nephros, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$2.64
- - -
-18.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000